Bioinformatic approaches for identification of potential repurposable drugs in COVID-19
Journal of Drug Delivery and Therapeutics
; 11(1):13-22, 2021.
Article
in English
| CAB Abstracts | ID: covidwho-1409926
ABSTRACT
Introduction:
Repurposing existing drugs approved for other conditions is crucial to identifying specific therapeutics against SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) causing COVID-19 (coronavirus disease 2019) pandemic. Towards this attempt, it is important to understand how this virus hijacks the host system during the course of infection and determine potential virus- and host-targeted inhibitors.
Full text:
Available
Collection:
Databases of international organizations
Database:
CAB Abstracts
Language:
English
Journal:
Journal of Drug Delivery and Therapeutics
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS